Dr. Michael Joseph Dibiase, MD

Dr. Dibiase practices at San Luis Obispo Dialysis in Los Angeles, California.

Dr. Dibiase's NPI, 1316188048, was assigned on March 10, 2009. Dr. Dibiase graduated from Sidney Kimmel Medical College in 2007. Dr. Dibiase holds California license A106846.

Dr. Dibiase's primary practice is San Luis Obispo Dialysis, at 950 S Eastern Ave, Los Angeles, CA 90022 in Los Angeles County. The practice phone is (805) 543-1013.

Dr. Dibiase's primary practice is San Luis Obispo Dialysis in Los Angeles, California. Dr. Dibiase is also affiliated with Dignity Health - Marian Regional Medical Center. The medical group on file is Pacific Central Coast Health Centers Medical Group. Dmand AI also links Dr. Dibiase to 3 more hospitals, 3 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dibiase practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Dibiase's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Dibiase is board certified in internal medicine by the American Board of Internal Medicine. Dr. Dibiase is licensed in California.

Dmand AI lists acute kidney failure, asthma, chronic anemia, chronic diabetes, chronic hypertension, chronic kidney disease, fluid and electrolyte imbalances and kidney stone disease among the conditions Dr. Dibiase treats.

CMS data shows 1,652 Medicare services from Dr. Dibiase across 11 procedure codes in 2024, for 363 Medicare patients. Medicare paid $179,077 for them.

CMS counts 363 Medicare patients who saw Dr. Dibiase in 2024. The largest group is 75 to 84, with 156 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 3.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dibiase's median patient age at 73, with 40% women.

In 2024, Dr. Dibiase wrote 1,385 Medicare Part D claims for 240 patients. 83% of them were for generic drugs. CMS names the drug for 1,151 of them, across 36 drugs with 11 or more claims each, at $460,850 in total drug cost. In 2023, CMS named 1,222 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 23 out of 100 for Dr. Dibiase for performance year 2024, reported individually. Dr. Dibiase accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dibiase as offering telehealth.

CMS Open Payments shows 42 general payments to Dr. Dibiase from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Baxter Healthcare paid the most, $229. It also lists 8 research payments totaling $1,506 in 2016.

Dr. Dibiase graduated from Sidney Kimmel Medical College in 2007. Dr. Dibiase is a member of ACP, AMA, ASN and NKF.

Dr. Dibiase is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.